These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
144 related articles for article (PubMed ID: 372234)
1. The modification of biophysical and endotoxic properties of bacterial lipopolysaccharides by serum. Ulevitch RJ; Johnston AR J Clin Invest; 1978 Dec; 62(6):1313-24. PubMed ID: 372234 [TBL] [Abstract][Full Text] [Related]
2. New function for high density lipoproteins. Their participation in intravascular reactions of bacterial lipopolysaccharides. Ulevitch RJ; Johnston AR; Weinstein DB J Clin Invest; 1979 Nov; 64(5):1516-24. PubMed ID: 227936 [TBL] [Abstract][Full Text] [Related]
3. Interactions of bacterial lipopolysaccharide with acute-phase rabbit serum and isolation of two forms of rabbit serum amyloid A. Tobias PS; McAdam KP; Ulevitch RJ J Immunol; 1982 Mar; 128(3):1420-7. PubMed ID: 7057038 [TBL] [Abstract][Full Text] [Related]
4. Effect of detoxification processes on the interferon-inducing activity of bacterial endotoxins. Sourek J; Jandejsek J; Levin J Acta Microbiol Hung; 1989; 36(4):439-43. PubMed ID: 2484274 [TBL] [Abstract][Full Text] [Related]
5. The effect of complement depletion on bacterial lipopolysaccharide (LPS)-induced hemodynamic and hematologic changes in the Rhesus monkey. Ulevitch RJ; Cochrane CG; Bangs K; Herman CM; Fletcher JR; Rice CL Am J Pathol; 1978 Jul; 92(1):227-40. PubMed ID: 99042 [TBL] [Abstract][Full Text] [Related]
6. Interactions of bacterial lipopolysaccharides with tissue macrophages and plasma lipoproteins. Maier RV; Mathison JC; Ulevitch RJ Prog Clin Biol Res; 1981; 62():133-55. PubMed ID: 7025010 [TBL] [Abstract][Full Text] [Related]
7. New function for high density lipoproteins. Isolation and characterization of a bacterial lipopolysaccharide-high density lipoprotein complex formed in rabbit plasma. Ulevitch RJ; Johnston AR; Weinstein DB J Clin Invest; 1981 Mar; 67(3):827-37. PubMed ID: 7204557 [TBL] [Abstract][Full Text] [Related]
8. Lipopolysaccharide-binding factors are present in bovine serum. Khemlani LS; Bochsler PN; Maddux JM Biofactors; 1992 Dec; 4(1):33-6. PubMed ID: 1292474 [TBL] [Abstract][Full Text] [Related]
9. The interaction of Escherichia coli with normal human serum: the kinetics of serum-mediated lipopolysaccharide release and its dissociation from bacterial killing. Tesh VL; Duncan RL; Morrison DC J Immunol; 1986 Aug; 137(4):1329-35. PubMed ID: 3525676 [TBL] [Abstract][Full Text] [Related]
10. Binding sites for endotoxic lipopolysaccharide on the plasma membrane of isolated rabbit hepatocytes. Ramadori G; Hopf U; Meyer zum Büschenfelde KH Acta Hepatogastroenterol (Stuttg); 1979 Oct; 26(5):368-74. PubMed ID: 393040 [TBL] [Abstract][Full Text] [Related]
11. Control of lipopolysaccharide-high density lipoprotein binding by acute phase protein(s). Tobias PS; Ulevitch RJ J Immunol; 1983 Oct; 131(4):1913-6. PubMed ID: 6311900 [TBL] [Abstract][Full Text] [Related]
12. The selective binding of aggregated IgG to lipid A-rich bacterial lipopolysaccharides. Ginsberg MH; Morrison DC J Immunol; 1978 Jan; 120(1):317-9. PubMed ID: 627721 [TBL] [Abstract][Full Text] [Related]
13. A synthetic lipopolysaccharide-binding peptide based on amino acids 27-39 of serum amyloid P component inhibits lipopolysaccharide-induced responses in human blood. de Haas CJ; van der Tol ME; Van Kessel KP; Verhoef J; Van Strijp JA J Immunol; 1998 Oct; 161(7):3607-15. PubMed ID: 9759883 [TBL] [Abstract][Full Text] [Related]
14. Differential clearance and induction of host responses by various administered or released lipopolysaccharides. Hasunuma R; Morita H; Tanaka S; Ryll R; Freudenberg MA; Galanos C; Kumazawa Y J Endotoxin Res; 2001; 7(6):421-9. PubMed ID: 11753211 [TBL] [Abstract][Full Text] [Related]
15. Bartonella quintana lipopolysaccharide effects on leukocytes, CXC chemokines and apoptosis: a study on the human whole blood and a rat model. Matera G; Liberto MC; Quirino A; Barreca GS; Lamberti AG; Iannone M; Mancuso E; Palma E; Cufari FA; Rotiroti D; Focà A Int Immunopharmacol; 2003 Jun; 3(6):853-64. PubMed ID: 12781702 [TBL] [Abstract][Full Text] [Related]
16. Inhibition of endotoxin response by e5564, a novel Toll-like receptor 4-directed endotoxin antagonist. Mullarkey M; Rose JR; Bristol J; Kawata T; Kimura A; Kobayashi S; Przetak M; Chow J; Gusovsky F; Christ WJ; Rossignol DP J Pharmacol Exp Ther; 2003 Mar; 304(3):1093-102. PubMed ID: 12604686 [TBL] [Abstract][Full Text] [Related]
17. Biologic properties of nontoxic derivatives of a lipopolysaccharide from Escherichia coli K235. McIntire FC; Hargie MP; Schenck JR; Finley RA; Sievert HW; Rietschel ET; Rosenstreich DL J Immunol; 1976 Aug; 117(2):674-8. PubMed ID: 781135 [TBL] [Abstract][Full Text] [Related]
18. Lipid A, the active part of bacterial endotoxins in inducing serum colony stimulating activity and proliferation of splenic granulocyte/macrophage progenitor cells. Apte RN; Galanos C; Pluznik DH J Cell Physiol; 1976 Jan; 87(1):71-8. PubMed ID: 1081990 [TBL] [Abstract][Full Text] [Related]
19. Biological effects of Veillonella parvula and Bacteroides intermedius lipopolysaccharides. Matera G; Liberto MC; Berlinghieri MC; Focà A Microbiologica; 1991 Oct; 14(4):315-23. PubMed ID: 1775087 [TBL] [Abstract][Full Text] [Related]
20. Membrane receptors of human erythrocytes for bacterial lipopolysaccharide (LPS). Yokoyama K; Terao T; Osawa T Jpn J Exp Med; 1978 Dec; 48(6):511-7. PubMed ID: 374801 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]